Do We Need Surveillance Urethro-Cystoscopy in Patients with Neurogenic Lower Urinary Tract Dysfunction?

To examine the value of surveillance urethro-cystoscopy in patients with neurogenic lower urinary tract dysfunction (NLUTD) in regard to the conflicting literature as it is generally agreed that patients with NLUTD are at increased risk for bladder cancer.In a cross-sectional study, a consecutive se...

Full description

Bibliographic Details
Main Authors: Ulla Sammer, Matthias Walter, Stephanie C Knüpfer, Ulrich Mehnert, Beata Bode-Lesniewska, Thomas M Kessler
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4626398?pdf=render
_version_ 1811306097352376320
author Ulla Sammer
Matthias Walter
Stephanie C Knüpfer
Ulrich Mehnert
Beata Bode-Lesniewska
Thomas M Kessler
author_facet Ulla Sammer
Matthias Walter
Stephanie C Knüpfer
Ulrich Mehnert
Beata Bode-Lesniewska
Thomas M Kessler
author_sort Ulla Sammer
collection DOAJ
description To examine the value of surveillance urethro-cystoscopy in patients with neurogenic lower urinary tract dysfunction (NLUTD) in regard to the conflicting literature as it is generally agreed that patients with NLUTD are at increased risk for bladder cancer.In a cross-sectional study, a consecutive series of 129 patients (50 females, 79 males, mean age 51, range 18-88) suffering from NLUTD for at least 5 years was prospectively investigated using urethro-cystoscopy and bladder washing cytology at a single university spinal cord injury (SCI) center.Due to suspicious urethro-cystoscopy and/or bladder washing cytology findings, 13 (10%) of 129 patients underwent transurethral resection of the bladder lesion and/or random bladder biopsies. Overall, 9 relevant histological findings were found in 5% (7/129) of our patients: bladder melanosis (n = 1), nephrogenic adenoma (n = 3), keratinizing squamous metaplasia (n = 1), intestinal metaplasia (n = 3), and muscle-invasive adenocarcinoma of the bladder (n = 1).Using surveillance urethro-cystoscopy, we found relevant histological findings in 5% of our patients suffering from NLUTD for at least 5 years. Thus, surveillance urethro-cystoscopy might be warranted, although the ideal starting point and frequency remain to be determined in further prospective studies.
first_indexed 2024-04-13T08:38:19Z
format Article
id doaj.art-df902bf4bcfc47b396fe8726df5d7572
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T08:38:19Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-df902bf4bcfc47b396fe8726df5d75722022-12-22T02:54:00ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011010e014097010.1371/journal.pone.0140970Do We Need Surveillance Urethro-Cystoscopy in Patients with Neurogenic Lower Urinary Tract Dysfunction?Ulla SammerMatthias WalterStephanie C KnüpferUlrich MehnertBeata Bode-LesniewskaThomas M KesslerTo examine the value of surveillance urethro-cystoscopy in patients with neurogenic lower urinary tract dysfunction (NLUTD) in regard to the conflicting literature as it is generally agreed that patients with NLUTD are at increased risk for bladder cancer.In a cross-sectional study, a consecutive series of 129 patients (50 females, 79 males, mean age 51, range 18-88) suffering from NLUTD for at least 5 years was prospectively investigated using urethro-cystoscopy and bladder washing cytology at a single university spinal cord injury (SCI) center.Due to suspicious urethro-cystoscopy and/or bladder washing cytology findings, 13 (10%) of 129 patients underwent transurethral resection of the bladder lesion and/or random bladder biopsies. Overall, 9 relevant histological findings were found in 5% (7/129) of our patients: bladder melanosis (n = 1), nephrogenic adenoma (n = 3), keratinizing squamous metaplasia (n = 1), intestinal metaplasia (n = 3), and muscle-invasive adenocarcinoma of the bladder (n = 1).Using surveillance urethro-cystoscopy, we found relevant histological findings in 5% of our patients suffering from NLUTD for at least 5 years. Thus, surveillance urethro-cystoscopy might be warranted, although the ideal starting point and frequency remain to be determined in further prospective studies.http://europepmc.org/articles/PMC4626398?pdf=render
spellingShingle Ulla Sammer
Matthias Walter
Stephanie C Knüpfer
Ulrich Mehnert
Beata Bode-Lesniewska
Thomas M Kessler
Do We Need Surveillance Urethro-Cystoscopy in Patients with Neurogenic Lower Urinary Tract Dysfunction?
PLoS ONE
title Do We Need Surveillance Urethro-Cystoscopy in Patients with Neurogenic Lower Urinary Tract Dysfunction?
title_full Do We Need Surveillance Urethro-Cystoscopy in Patients with Neurogenic Lower Urinary Tract Dysfunction?
title_fullStr Do We Need Surveillance Urethro-Cystoscopy in Patients with Neurogenic Lower Urinary Tract Dysfunction?
title_full_unstemmed Do We Need Surveillance Urethro-Cystoscopy in Patients with Neurogenic Lower Urinary Tract Dysfunction?
title_short Do We Need Surveillance Urethro-Cystoscopy in Patients with Neurogenic Lower Urinary Tract Dysfunction?
title_sort do we need surveillance urethro cystoscopy in patients with neurogenic lower urinary tract dysfunction
url http://europepmc.org/articles/PMC4626398?pdf=render
work_keys_str_mv AT ullasammer doweneedsurveillanceurethrocystoscopyinpatientswithneurogeniclowerurinarytractdysfunction
AT matthiaswalter doweneedsurveillanceurethrocystoscopyinpatientswithneurogeniclowerurinarytractdysfunction
AT stephaniecknupfer doweneedsurveillanceurethrocystoscopyinpatientswithneurogeniclowerurinarytractdysfunction
AT ulrichmehnert doweneedsurveillanceurethrocystoscopyinpatientswithneurogeniclowerurinarytractdysfunction
AT beatabodelesniewska doweneedsurveillanceurethrocystoscopyinpatientswithneurogeniclowerurinarytractdysfunction
AT thomasmkessler doweneedsurveillanceurethrocystoscopyinpatientswithneurogeniclowerurinarytractdysfunction